ENT Devices | Market Insights | US | 2024
The US ENT device market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022. Growth over the forecast period will be driven mainly by the nasal packing device segment, followed by the ENT RF and Powered Instruments market. In the previous iteration, sinus stent market revenues were anticipated to grow modestly, based on favorable clinical trial data and positive feedback from clinicians; however, analysis of recently published financial data has revealed slower than anticipated growth in sinus stent sales. As a result, sinus stent unit and revenue projections have been adjusted downward, relative to the previous market forecast.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in the US from 2019 through 2032.
